ABOUT US
About Us
Saving Lives Every Day
About Us
Saving Lives Every Day
The field of addiction treatment has not seen any major diagnostic or treatment advances in over 30 years, until now.
Our geneticists are the pioneers that discovered the DNA mutations that create risk for addiction and behavioral disease. iVitalize is a genetic technology company that has developed groundbreaking genetic diagnostics and solutions for addiction and behavioral disease.
We created a new field of science now taught in medical schools called Reward Deficiency Syndrome (RDS), which is the driver for behavioral disease
We discovered the first gene linked to addiction and behavioral disease driven by Reward Deficiency Syndrome
We have developed neuro-nutrient solutions for behavioral disease and are also developing new technologies that will correct behavioral genetic mutations
Our healthcare visionaries are deploying our portfolio of proprietary genetic solutions to millions of people worldwide
We created GARS (Genetic Addiction Risk Severity), the first and only patented genetic test to identify epigenetic mutation to determine specific behavioral disease in individuals
We created personalized epigenetic neuronutrients to treat behavioral disease
Our scientists are pioneers of new genetic technologies including geneticists from the National Human Genome Center in Washington, DC
We are currently developing solutions for epigenetic behavioral disease
We have some of the industry-leading geneticists developing our technologies and healthcare visionaries bringing our solutions to millions of people around the word
We created a new field of science now taught in medical schools called Reward Deficiency Syndrome (RDS), which is the driver for behavioral disease
We discovered the first gene linked to addiction and behavioral disease driven by Reward Deficiency Syndrome
We have developed neuro-nutrient solutions for behavioral disease and are also developing new technologies that will correct behavioral genetic mutations
Our healthcare visionaries are deploying our portfolio of proprietary genetic solutions to millions of people worldwide
We created GARS (Genetic Addiction Risk Severity), the first and only patented genetic test to identify epigenetic mutation to determine specific behavioral disease in individuals
We created personalized epigenetic neuronutrients to treat behavioral disease
Our scientists are pioneers of new genetic technologies including geneticists from the National Human Genome Center in Washington, DC
We are currently developing solutions for epigenetic behavioral disease
We have some of the industry-leading geneticists developing our technologies and healthcare visionaries bringing our solutions to millions of people around the word
Our Companies
Our Companies
The iVitalize family of companies are at the forefront of genetic technology, working seamlessly toward the goal of Epigenetic Resolution of diseases caused by genetic mutation.
By collaborating and understanding the entire process, from research to delivery, our teams have been able to introduce change and innovation where none has existed for decades. In unison, we excel at helping clinicians and clients save and transform lives.
Our teams have been able to introduce change and innovation
The iVitalize family of companies are at the forefront of genetic technology, working seamlessly toward the goal of Epigenetic Resolution of diseases caused by genetic mutation.
By collaborating and understanding the entire process, from research to delivery, our teams have been able to introduce change and innovation where none has existed for decades. In unison, we excel at helping clinicians and clients save and transform lives.
Our teams have been able to introduce change and innovation
In The News
PHARMA TECH 2018 TOP 10 GENETIC CENTERS
COVER STORY OF SOBER WORLD
COVER STORY OF SOBER WORLD
In The News
PHARMA TECH 2018 TOP 10 GENETIC CENTERS
COVER STORY OF SOBER WORLD
COVER STORY OF SOBER WORLD
Organizations
We have partnered and collaborated with some of the most respected academic and research institutions nationwide and internationally
Organizations
We have partnered and collaborated with some of the most respected academic and research institutions nationwide and internationally
Recent Accomplishments
Recent Accomplishments
“Top 100 Healthcare Visionaries” award from International Forum on Advancements in Healthcare (IFAH)
2015 – 2019 CAP Center of Excellence award
We are one of less than fifty nationally designated genetics labs by Centers for Disease Control and Prevention (CDC)
Funded by the NIH for a new standard of care with GARS Grant # 1R41MD012318-01
GARS accepted for FDA Breakthrough Technology Submission and pending final FDA approval
Awarded multiple VA contracts and received highest quality rating from VA for our molecular testing
2018 Top 10 Innovative Genetic Testing Company (Pharma Tech)
Featured in Sober World magazine, Campus Recovery magazine, Spectrum News, CBS News, and dozens of domestic and international conferences
Collaborative genetic partner with the U.S. National Human Genome Center in Washington, DC
Became first genetic test is U.S history to receive a full patent. Patent # 10,072,289 B2. Patented in over 20 countries globally
